Navigation Links
Omeros Appoints New Vice President of Clinical Development
Date:8/5/2009

SEATTLE, Aug. 5 /PRNewswire/ -- Omeros Corporation today announced the appointment of Stephen R. Murray, M.D., Ph.D. as Vice President of Clinical Development. Dr. Murray will oversee clinical trial strategies and protocols at Omeros, and currently is leading the ongoing clinical studies for Omeros' PharmacoSurgery(TM) product candidates. These include OMS103HP, the Company's lead candidate being evaluated in a Phase 3 clinical program for improved joint function and pain reduction following arthroscopic surgery, OMS302 in a Phase 2 program for use in cataract surgery, and OMS201 in a Phase 1/2 program for use in uroendoscopy.

"Dr. Murray brings a wealth of experience in the pharmaceutical industry, having successfully directed a number of development programs in both large and small pharmaceutical companies," said Gregory A. Demopulos, M.D., Chairman & CEO of Omeros. "Dr. Murray will work closely with our team members to continue building the long-term value of Omeros and our products."

"Omeros is poised to deliver important new treatments to patients through its PharmacoSurgery platform," said Dr. Murray. "In addition, we have several preclinical central nervous system and inflammation programs that have the potential to address significant unmet medical needs. This is an important time for Omeros and I'm excited to play a role here."

Prior to Omeros, Dr. Murray served in various positions, most recently as Chief Medical Officer at Memory Pharmaceuticals, a biopharmaceutical company that developed treatments for central nervous system disorders and was acquired by Hoffman-La Roche Inc. in January 2009. Before that, Dr. Murray held various positions at Pfizer Global Pharmaceuticals, including senior medical director and therapeutic team leader for schizophrenia. Dr. Murray received his M.D. and Ph.D. in molecular and cellular biology from the Medical University of South Carol
'/>"/>

SOURCE Omeros Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
2. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
3. Omeros and BlueCrest Announce $20 Million Debt Facility
4. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
5. Omeros Appoints David A. Mann to its Board of Directors
6. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
7. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
8. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
9. Brookstone Pharmaceuticals Appoints New Corporate Position
10. PDI Appoints Gerald P. Belle as Lead Independent Director
11. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009).../ -- Dr. Mate Hidvegi, inventor of Avemar fermente...issued on November 17 by Biropharma Kft, discredit...f-serving statements about its U.S. competitor Ame...his office in Budapest, Hungary: ,, "The Birop... to AveULTRA, www.aveultra.com , is misleading....
(Date:11/19/2009)...9 MONITORING FORCE GmbH,announced ...serin in the,indication treatment-relevant levodop...phan drug status designation with the European Med...is a complication of the mainstay,treatment in adv...those,affected, since it may be disabling for the ...
(Date:11/19/2009)...9 AFFiRiS AG will focus its,Alzhei...an unexpectedly early,stage of development: the va...e II clinical trial early in 2010. This decision b...f two Phase I trials with the candidates,AD01 and ...irst interim,analysis of the secondary endpoints a...
(Date:11/18/2009)... developing new sensors to detect chemical agents ...inst the threat of terrorist attacks. , The devi...dual or crime scene to gather a sample which is th...ct the presence of chemicals within seconds. This ...response to terrorist threats. , The scanning i...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
...rissa Tan, Rob Park, and Keith Hamby,Bio-Rad La... CA 94547 USA, , , Introduc... effective technique for accurate quantitation ,...le gene involve careful choice , of prime...the amplified , DNA product. In addition,...
..., Allora Aguilera, Chate Luu, Ivan Huang,Diana ...is Simonyi, Jim Wong, Quan Nguyen , , ...000 Alfred Nobel Drive, , Hercules, CA 94...r at The American Society for Cell Biology , ...CA , , , , , ...
...ris Simonyi, and Claudia Suen, Bio-Rad Laboratorie...4547 USA , , Introduction ,...e for detecting phosphorylated , proteins...e lysates. In , recent years, new techniq...h , have become available for detecting p...
Other Biology Technology:Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 2Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 3Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 4Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 5Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 6Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 7Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 8Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 9Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 10Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 11Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A 12Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 2Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 3Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 4Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A 5
(Date:11/23/2009)... biomedical engineer and cardiologist Tzung "John"...ans distinguish cardiac emergencies requiring imme...h drugs and lifestyle change. , Angiograms, imag...eding the heart, offer an inside view of the inter...n revealing deposits of a dangerous fatty substanc...
(Date:11/23/2009)...edical Sciences (NIGMS), part of the National Inst... for grants in scientific areas it identified as "...ant program to stimulate biomedical research and t...covery and Reinvestment Act (Recovery Act). , "T...significant impact on a field of biomedical scienc...
(Date:11/23/2009)...tor of the Interuniversity Professorship in Law an...niversity of the Basque Country. The Professorship...experts such as researchers in the fields of molec...ics. , The Interuniversity Professorship in Law ...o and the Basque Country was created in 1993. The ...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2Nutrigenomics researchers replicate gene interaction with saturated fat 10760 1Nutrigenomics researchers replicate gene interaction with saturated fat 10760 2Nutrigenomics researchers replicate gene interaction with saturated fat 10760 3Some prescription meds can harm fetus 10758 1Some prescription meds can harm fetus 10758 2China Business Knowledge Launches 26amp 3B 238220 3BChina Prospects Forum 26amp 3B 238221 3B Dec 9 2009 New York City 14873 1China Business Knowledge Launches 26amp 3B 238220 3BChina Prospects Forum 26amp 3B 238221 3B Dec 9 2009 New York City 14873 2
...ment Software Provider to Offer Biometrics, ATLAN...ngerprint biometrics research and development firm...hip agreement with ZOLL Data Systems(R), an,indust...tment management,software, to provide fingerprint ...ers., Through the terms of this agreement, ZOLL D...
...Mass., July 10, 2008 -- Thomas E. Smith, associate...een awarded a $217,710 three-year grant by the Nat...f Health (NIH) for "Asymmetric Methods for the Syn..." , "This research is concerned with the developm...nt preparation of anticancer compounds," said Smit...
...r action sends a million electrical signals pulsin...f generating these electrical impulses is the ion ...iversity of Illinois measures movements smaller th...movement is critical to how these tiny pores in th...ges in voltage across the membrane. The findings a...
Other Biology News:M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software 2Researchers catch ion channels in their opening act 2Researchers catch ion channels in their opening act 3
...ystems Cell and Tissue Staining Kits are intended ...istological and cytological specimens. These kits ...ed by either R&D Systems or by other vendors. Brie...idin-Biotin Complex (ABC) with primary antibodies ...
microTOFLC from Bruker Daltonics
...lar uptake of long double stranded RNA (dsRNA) has...e group of organisms as well as insect cells in cu... protein expression by utilizing sequence-specific...er RNA (mRNA). Attempts to induce RNA interference...
...r Daltonics and Bruker BioSpins Metabolic Profiler... and analysis of complex mixtures. It features an ...MR spectrometer and integrated software for data a...r applications like:,Assessment of the metabolic p...
Biology Products: